Alterations in Surface Hydrophobicity of Acinetobacter Baumannii Induced by Meropenem

Overview

Journal Folia Microbiol (Praha)

Publisher Springer

Specialty Microbiology

Date 2000 Feb 9

PMID 10664881

Citations 5

Authors

A Hostacka

Affiliations

Soon will be listed here.

Abstract

Six strains of Acinetobacter baumannii out of eleven strains tested revealed a strong hydrophobic character. This was demonstrated by adherence of bacteria to xylene in the range of 90-94%. Changes in surface hydrophobicity of these strains were studied after treatment with meropenem at subinhibitory concentrations (sub-MICs) (1/4, 1/8, 1/16 or 1/32 of the MICs). All strains showed a reduced adherence to xylene after the action of meropenem at 1/4 or 1/16 of the MICs. Hydrophobicity of the treated bacteria was decreased to 1.3-70% (1/16 of the MICs) or to 12-86% (1/4 of the MICs), depending on the strain. A decrease in surface hydrophobicity of three strains was also observed after their exposure to meropenem at 1/8 of the MICs (to 18-71% of the control values). Meropenem at 1/32 of the MICs practically did not affect bacterial hydrophobic properties, with the exception of one strain.

Citing Articles

Characteristics of clinical Acinetobacter spp. strains.

Hostacka A, Klokocnikova L Folia Microbiol (Praha). 2002; 47(5):579-82.

PMID: 12503407 DOI: 10.1007/BF02818801.

Toxinogenicity and markers of pathogenicity of Pseudomonas aeruginosa strains isolated from patients with tumor diseases.

Majtan V, Hostacka A, Majtanova L, Trupl J Folia Microbiol (Praha). 2002; 47(4):445-9.

PMID: 12422526 DOI: 10.1007/BF02818706.

Influence on Enterobacter cloacae metabolism, cell-surface hydrophobicity and motility of suprainhibitory concentrations of carbapenems.

Majtan V, Majtanova L Folia Microbiol (Praha). 2002; 46(6):505-10.

PMID: 11898339 DOI: 10.1007/BF02817993.

Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli.

Latrache H, Bourlioux P, Karroua M, Zahir H, Hakkou A Folia Microbiol (Praha). 2001; 45(6):485-90.

PMID: 11501411 DOI: 10.1007/BF02818714.

Postantibiotic leukocyte enhancement of meropenem against gram-positive and gram-negative strains.

Novelli A, Fallani S, Cassetta M, Conti S, Mazzei T Antimicrob Agents Chemother. 2000; 44(11):3174-6.

PMID: 11036045 PMC: 101625. DOI: 10.1128/AAC.44.11.3174-3176.2000.

References

Bello H, Gonzalez G, Dominguez M, Zemelman R, Garcia A, Mella S . Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals. Diagn Microbiol Infect Dis. 1997; 28(4):183-6. DOI: 10.1016/s0732-8893(97)00074-6. View

Hostacka A . Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones. Microbios. 1997; 91(368-369):137-43. View

Mulin B, Talon D, Viel J, Vincent C, Leprat R, Thouverez M . Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 1995; 14(7):569-76. DOI: 10.1007/BF01690727. View

Gristina A . Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987; 237(4822):1588-95. DOI: 10.1126/science.3629258. View

Desnottes J, Diallo N, Moret G, Santonja R . Effects of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells. Drugs Exp Clin Res. 1987; 13(2):69-73. View

Seifert H, Baginski R, Schulze A, Pulverer G . Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother. 1993; 37(4):750-3. PMC: 187751. DOI: 10.1128/AAC.37.4.750. View

French G, Casewell M, Roncoroni A, Knight S, Phillips I . A hospital outbreak of antibiotic-resistant Acinetobacter anitratus: epidemiology and control. J Hosp Infect. 1980; 1(2):125-31. DOI: 10.1016/0195-6701(80)90044-4. View

Crowe M, Towner K, Humphreys H . Clinical and epidemiological features of an outbreak of acinetobacter infection in an intensive therapy unit. J Med Microbiol. 1995; 43(1):55-62. DOI: 10.1099/00222615-43-1-55. View

Jones R, Barry A, Thornsberry C . In-vitro studies of meropenem. J Antimicrob Chemother. 1989; 24 Suppl A:9-29. DOI: 10.1093/jac/24.suppl_a.9. View

10.

Buisson Y, Tran Van Nhieu G, Ginot L, Bouvet P, SCHILL H, Driot L . Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage. J Hosp Infect. 1990; 15(1):83-93. DOI: 10.1016/0195-6701(90)90024-i. View

11.

Paton R, Hood J, Miles R, Amyes S . ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents. 1993; 2(2):81-7. DOI: 10.1016/0924-8579(93)90045-7. View

12.

Modakkas E, SANYAL S . Imipenem resistance in aerobic gram-negative bacteria. J Chemother. 1998; 10(2):97-101. DOI: 10.1179/joc.1998.10.2.97. View

13.

Nomura S, Nagayama A . Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime. Chemotherapy. 1995; 41(4):267-75. DOI: 10.1159/000239355. View

14.

Braga P, Dal Sasso M, Maci S, Reggio S, Piatti G . Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of Escherichia coli. Chemotherapy. 1995; 41(1):50-8. DOI: 10.1159/000239324. View

15.

Williams P . Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae. Antimicrob Agents Chemother. 1987; 31(5):758-62. PMC: 174828. DOI: 10.1128/AAC.31.5.758. View

16.

Tawfik A, Ramadan M, Shibl A . Inhibition of motility and adherence of Proteus mirabilis to uroepithelial cells by subinhibitory concentrations of amikacin. Chemotherapy. 1997; 43(6):424-9. DOI: 10.1159/000239601. View

17.

Grimwood K, To M, Rabin H, Woods D . Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob Agents Chemother. 1989; 33(1):41-7. PMC: 171418. DOI: 10.1128/AAC.33.1.41. View

18.

Tilley P, Roberts F . Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin Infect Dis. 1994; 18(6):896-900. DOI: 10.1093/clinids/18.6.896. View

19.

Tateda K, Ishii Y, Hirakata Y, Matsumoto T, Ohno A, Yamaguchi K . Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity. J Antimicrob Chemother. 1994; 34(6):931-42. DOI: 10.1093/jac/34.6.931. View

20.

van Loosdrecht M, Lyklema J, Norde W, Schraa G, Zehnder A . The role of bacterial cell wall hydrophobicity in adhesion. Appl Environ Microbiol. 1987; 53(8):1893-7. PMC: 204020. DOI: 10.1128/aem.53.8.1893-1897.1987. View